| Preliminary assessment of the safety and immunogenicity of a new CTXΦ-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate JA Benítez, L García, A Silva, H García, R Fando, B Cedré, A Pérez, ... Infection and immunity 67 (2), 539-545, 1999 | 133 | 1999 |
| The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers L García, MD Jidy, H García, BL Rodríguez, R Fernández, B Cedré, ... Infection and immunity 73 (5), 3018-3024, 2005 | 123 | 2005 |
| VGJφ, a novel filamentous phage of Vibrio cholerae, integrates into the same chromosomal site as CTXφ J Campos, E Martínez, E Suzarte, BL Rodríguez, K Marrero, Y Silva, ... Journal of bacteriology 185 (19), 5685-5696, 2003 | 113 | 2003 |
| Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A A Robert, A Silva, JA Benitez, BL Rodriguez, R Fando, J Campos, ... Vaccine 14 (16), 1517-1522, 1996 | 81 | 1996 |
| Novel type of specialized transduction for CTXφ or its satellite phage RS1 mediated by filamentous phage VGJφ in Vibrio cholerae J Campos, E Martínez, K Marrero, Y Silva, BL Rodríguez, E Suzarte, ... Journal of bacteriology 185 (24), 7231-7240, 2003 | 79 | 2003 |
| Production and Characterization of Monoclonal Antibodies to E1 Tor Toxin Co-Regulated Pilus of Vibrio cholerae G Falero, BL Rodríguez, I Rodríguez, J Campos, T Ledon, E Valle, Y Silva, ... Hybridoma and hybridomics 22 (5), 315-320, 2003 | 79 | 2003 |
| La pandemia subvalorada del siglo XXI: el virus del papiloma humano. Su repercusión en la patogenia del cáncer cervicouterino A Zelada-Valdés, RA Fando-Calzada Revista CENIC: Ciencias Biológicas 44 (2), 2013 | 64* | 2013 |
| VEJφ, a novel filamentous phage of Vibrio cholerae able to transduce the cholera toxin genes J Campos, E Martínez, Y Izquierdo, R Fando Microbiology 156 (1), 108-115, 2010 | 54 | 2010 |
| Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains JA Benitez, AJ Silva, BL Rodriguez, R Fando, J Campos, A Robert, ... Archives of medical research 27, 275-284, 1996 | 54 | 1996 |
| Anaerobic growth promotes synthesis of colonization factors encoded at the Vibrio pathogenicity island in Vibrio cholerae El Tor K Marrero, A Sánchez, A Rodríguez-Ulloa, LJ González, ... Research in microbiology 160 (1), 48-56, 2009 | 49 | 2009 |
| Differential interleukin-8 response of intestinal epithelial cell line to reactogenic and nonreactogenic candidate vaccine strains of Vibrio cholerae BL Rodrı́guez, A Rojas, J Campos, T Ledon, E Valle, W Toledo, R Fando Infection and immunity 69 (1), 613-616, 2001 | 42 | 2001 |
| Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus F Pazos, A Valle, D Martínez, A Ramírez, L Calderón, A Pupo, M Tejuca, ... Toxicon 48 (8), 1083-1094, 2006 | 39 | 2006 |
| Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638 E Valle, T Ledón, B Cedré, J Campos, T Valmaseda, B Rodríguez, ... Infection and immunity 68 (11), 6411-6418, 2000 | 39 | 2000 |
| Periplasmic proteins encoded by VCA0261–0260 and VC2216 genes together with copA and cueR products are required for copper tolerance but not for virulence in Vibrio cholerae K Marrero, A Sánchez, LJ González, T Ledón, A Rodríguez-Ulloa, ... Microbiology 158 (8), 2005-2016, 2012 | 35 | 2012 |
| Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxins D Pentón, V Pérez-Barzaga, I Díaz, ML Reytor, J Campos, R Fando, ... Protein Engineering, Design & Selection 24 (6), 485-493, 2011 | 32 | 2011 |
| Cys mutants in functional regions of Sticholysin I clarify the participation of these residues in pore formation A Valle, A López-Castilla, L Pedrera, D Martínez, M Tejuca, J Campos, ... Toxicon 58 (1), 8-17, 2011 | 31 | 2011 |
| Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults R Valera, HM García, MD Jidy, M Mirabal, MI Armesto, R Fando, L García, ... Vaccine 27 (47), 6564-6569, 2009 | 30 | 2009 |
| Construction and characterisation of O139 cholera vaccine candidates T Ledón, E Valle, T Valmaseda, B Cedré, J Campos, BL Rodrı́guez, ... Vaccine 21 (11-12), 1282-1291, 2003 | 25 | 2003 |
| Replicating function of the RS1 element associated with Vibrio cholerae CTXΦ prophage J Campos, R Fando, A Silva, BL Rodriguez, JA Benitez FEMS microbiology letters 164 (1), 141-147, 1998 | 24 | 1998 |
| TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera T Ledón, B Ferrán, C Pérez, E Suzarte, J Vichi, K Marrero, R Oliva, ... Microbes and infection 14 (11), 968-978, 2012 | 23 | 2012 |
Javier Campos GómezScientist, University of Alabama at BirminghamVerified email at sri.org
